Decreased CD3‐mediated interferon‐γ production in relapsing‐remitting multiple sclerosis

Annals of Neurology

Volumn 37, Issue 4, 1995, Pages 546-549

  Brod, Staley A ^a   Khan, Mohammed ^a   Bright, John ^c   Sriram, Subramaniam ^c   Marshall, Gailen D ^a   Henninger, Evelyn M ^a   Kerman, Ronald H ^b   Wolinsky, Jerry S ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c Vanderbilt Stallworth Rehabilitation Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CONCANAVALIN A; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4; IONOMYCIN; MYRISTIC ACID DERIVATIVE; OKT 3; PALMITIC ACID DERIVATIVE;

ARTICLE; CONTROLLED STUDY; HUMAN; MONONUCLEAR CELL; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; RECURRENT DISEASE; REMISSION; SIGNAL TRANSDUCTION;

ANTIGENS, CD3; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMAN; INTERFERON TYPE II; MULTIPLE SCLEROSIS; SUPPORT, NON-U.S. GOV'T;

EID: 0028987125     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.410370418     Document Type: Article

References (19)

1. Activated suppressor cell function in severely disabled patients with multiple sclerosis
2. Multiple sclerosis
3. Defective CD3 mediated proliferation and LPS responsiveness in multiple sclerosis
4. New diagnostic criteria for multiple sclerosis
5. Rating neurological impairment in multiple sclerosis: an expanded disability status scale
6. Intensive immunosuppression in progressive multiple sclerosis: a randomized, three‐arm study of high dose intravenous cyclophosphamide, plasma exchange and ACTH
7. Suppression of relapsing experimental allergic encephalomyelitis in SJL/J mouse by oral administration of type 1 interferons
8. PPD‐, PWM‐, and PHA‐induced interferon in stable MS: association with HLA‐Dw2 antigen and clinical variables
9. Intermittent interferonemia and interferon responses in multiple sclerosis
10. IFN‐β decreases T cell activation and IFN‐β production in multiple sclerosis
11. 1
12. Oral tolerance to myelin basic protein and natural recovery from EAE are associated with down regulation of inflammatory cytokines and differential upregulation of TGF‐b, IL‐4 and prostaglandin E expression in the brain
13. T helper type 1 development of naive CD4 + T cells requires the coordinate action of IL‐12 and IFN‐γ and is inhibited by TGF‐β
14. Differential regulation of TGF‐β and IL‐2 genes in human T cells: demonstration of usage of novel competitor DNA constructs in the quantitative polymerase chain reaction
15. Genetic and mutational analysis of the T‐cell receptor
16. Structural T cell defects
17. Primary immunodeficiency caused by mutation in the gene encoding the CD3‐γ subunit of the T‐lymphocyte receptor
18. Selective disbalances of the peripheral T cell subsets in the human CD3‐γ deficiency
19. Independent mutations of the human CD3‐ε gene resulting in a T cell receptor/CD3 complex immunodeficiency